MétaCan
Menu
← Back to cohort

P038 Persistent inflammatory markers and deregulated immune response in clinical remission Crohn's disease patients treated with infliximab

2019· article· en· W2963606991 on OpenAlexaboutno aff
Murillo Duarte-Silva, Parra Rogerio, Feitosa Marley, Omar Féres, Rocha José Joaquim, Cardoso Cristina

Bibliographic record

VenueThe American Journal of Gastroenterology · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInfliximabCrohn's diseaseImmunologyInflammatory bowel diseaseImmune systemCalprotectinInternal medicineGastroenterologyAzathioprineIleitisDiseaseFaecal calprotectinTumor necrosis factor alpha

Abstract

fetched live from OpenAlex

BACKGROUND: The development of Inflammatory Bowel Diseases (IBD) comprises an imbalance among gut microbiota, genetic susceptibility and exacerbated immune responses, which predispose to chronic inflammation in affected patients, who are usually treated with biological agents such as anti-tumor necrosis factor-α (TNF-α). Despite that, even during clinical remission periods, Crohn’s disease (CD) patients may still present endoscopic disease activity and possibly a residual systemic inflammatory response. Therefore, in this study we aimed to evaluate the responsiveness and immune profile of peripheral blood mononuclear cells (PBMC) of infliximab-treated patients, as well as the relationship between the altered responses and the clinical disease presentation. METHODS: We enrolled 20 healthy controls (HC) and 39 CD patients, which were classified according to the Harvey-Bradshaw Index (HBI) and Simple Endoscopic Score for Crohn’s Disease (SES-CD). All were using anti-TNF-α therapy (infliximab), including 61.5% in combination with Azathioprine. RESULTS: Although 94% of the patients were in clinical remission, 51.3% presented disease mucosal activity. Considering the Montreal classification, 12.8% had colonic disease, while 33.4% had ileal and 53.8% ileocolonic disease. Most the patients developed complications, being 20.5% stenosis and 35.9% structuring disease, while 59% had perianal disease. The immunophenotyping identification of PBMC by flow cytometry showed increased CD14+ and CD14++CD16+ monocytes in CD, indicating a tendency towards an inflammatory response because of the increased CD16 expression, along with augmented NKT and decreased NK cells and B lymphocytes. Considering the population of regulatory lymphocytes, CD patients had increased CD4+CD25+CTLA-4+ and CD4+CD25+FOXP3+ cells, together with augmented expression of CTLA-4 and FOXP3 in CD4+CD25- and CD4+CD25+ lymphocytes, indicating the raising of an important systemic counter regulatory response. Nevertheless, there was an increase in the inflammatory cytokine IL-6 in plasma and when PBMC was restimulated in vitro with bacterial-derived lipopolysaccharide (LPS), CD patients produced more TNF than healthy controls. Indeed, plasma dosage of LPS pointed to increased detection in CD samples, suggesting that these patients still present bacteria translocation to circulation. CONCLUSION(S): Even in clinical remission, CD patients had a relevant systemic inflammatory response together with increased regulatory population, probably elicited in an attempt to achieve immune-regulation after biological therapy. Financial support: Fapesp # 2017/08651-1.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.224
Teacher spread0.220 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→